Categories
Change Password!
Reset Password!
Trial compares 1% Terbinafine vs 1% Clotrimazole C...
A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...
Study assesses efficacy of ketorolac for treatment...
In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...
Is alcohol safe for rheumatoid arthritis patients...
Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...
Clinical features of a headache or facial pain bef...
Herpes zoster (HZ) also known as shingles is a painful, blistering skin eruption in a dermatomal distribution. When the patients are suffering fr...
GERD Symptoms: Could Intermittent Fasting Help?
A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...
Does exercise induce GERD or relieve acid reflux?...
Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...
Study reveals the effect of Isotretinoin on menstr...
Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...
Understanding bleeding patterns associated with ea...
A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...
Lactation duration linked to blood pressure reduct...
A strong association exists between lactation duration and substantial reductions in both systolic and diastolic blood pressure (BP) a year after...
Tirzepatide injection gets FDA approval for chroni...
According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...
